Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 292,423 | 257,254 | 54,201 | 4,450 | N/A |
Marketable Securities | 403,329 | N/A | N/A | N/A | N/A |
Receivables | 1,029 | 1,079 | 1,086 | N/A | N/A |
Other current assets | 0 | 0 | 0 | 32,602 | 0 |
TOTAL | $708,151 | $265,383 | $57,456 | $37,534 | $N/A |
Non-Current Assets | |||||
PPE Net | 3,877 | 1,447 | 447 | 321 | N/A |
Other Non-Current Assets | 28,745 | 971 | 1,730 | 12,628 | 0 |
TOTAL | $32,622 | $2,418 | $2,177 | $12,949 | $N/A |
Total Assets | $740,773 | $267,801 | $59,633 | $50,483 | $N/A |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 762 | 1,153 | 2,088 | 1,404 | 0 |
Accrued Expenses | 17,540 | 11,621 | 5,616 | 2,585 | N/A |
Other current liabilities | N/A | N/A | 5,675 | 4,703 | N/A |
TOTAL | $22,817 | $16,442 | $15,255 | $31,876 | $N/A |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | 7,399 | N/A | N/A |
Deferred Revenues | 1,298 | 3,668 | 1,876 | 1,542 | N/A |
aiOther Non-Current Liabilities | 0 | 0 | 3,900 | 11,835 | 0 |
TOTAL | $41,988 | $16,204 | $15,896 | $11,835 | $N/A |
Total Liabilities | $64,805 | $32,646 | $31,151 | $43,711 | $N/A |
Shareholders' Equity | |||||
Shares Outstanding, K | 47,530 | 39,074 | N/A | N/A | N/A |
Common Shares | 5 | 4 | N/A | 0 | N/A |
Retained earnings | -331,093 | -189,341 | -99,146 | -37,451 | N/A |
Other shareholders' equity | -429 | 0 | 0 | 0 | 0 |
TOTAL | $675,968 | $235,155 | $28,482 | $6,772 | $N/A |
Total Liabilities And Equity | $740,773 | $267,801 | $59,633 | $50,483 | $0 |